ZIMDIVI Trademark

Trademark Overview

On Thursday, June 15, 2017, a trademark application was filed for ZIMDIVI with the United States Patent and Trademark Office. The USPTO has given the ZIMDIVI trademark a serial number of 87491262. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 1, 2021. This trademark is owned by Bristol-Myers Squibb Company. The ZIMDIVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
zimdivi

General Information

Serial Number87491262
Word MarkZIMDIVI
Filing DateThursday, June 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 28, 2021EXTENSION 5 GRANTED
Thursday, March 25, 2021EXTENSION 5 FILED
Tuesday, April 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, March 27, 2021NOTICE OF REVIVAL - E-MAILED
Friday, March 26, 2021EXTENSION RECEIVED WITH TEAS PETITION
Friday, March 26, 2021PETITION TO REVIVE-GRANTED
Friday, March 26, 2021TEAS PETITION TO REVIVE RECEIVED
Thursday, September 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 15, 2020EXTENSION 4 GRANTED
Tuesday, September 15, 2020EXTENSION 4 FILED
Tuesday, September 15, 2020TEAS EXTENSION RECEIVED
Saturday, March 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 5, 2020EXTENSION 3 GRANTED
Thursday, March 5, 2020EXTENSION 3 FILED
Thursday, March 5, 2020TEAS EXTENSION RECEIVED
Thursday, September 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2019EXTENSION 2 GRANTED
Tuesday, September 17, 2019EXTENSION 2 FILED
Tuesday, September 17, 2019TEAS EXTENSION RECEIVED
Wednesday, March 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2019EXTENSION 1 GRANTED
Monday, March 25, 2019EXTENSION 1 FILED
Monday, March 25, 2019TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, August 12, 2018EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, May 3, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 3, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 26, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2017NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 22, 2017ASSIGNED TO EXAMINER
Thursday, June 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 19, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

zimdivi diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection